176 related articles for article (PubMed ID: 32210117)
21. YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line.
Akiyama Y; Ashizawa T; Komiyama M; Miyata H; Oshita C; Omiya M; Iizuka A; Kume A; Sugino T; Hayashi N; Mitsuya K; Nakasu Y; Yamaguchi K
Oncol Rep; 2014 Jul; 32(1):159-66. PubMed ID: 24842123
[TBL] [Abstract][Full Text] [Related]
22. Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo.
Huang K; Chen Y; Zhang R; Wu Y; Ma Y; Fang X; Shen S
Cell Death Dis; 2018 Feb; 9(2):157. PubMed ID: 29410403
[TBL] [Abstract][Full Text] [Related]
23. Honokiol Induces Autophagic Apoptosis in Neuroblastoma Cells through a P53-Dependent Pathway.
Lin MC; Lee YW; Tseng YY; Lin YW; Chen JT; Liu SH; Chen RM
Am J Chin Med; 2019; 47(4):895-912. PubMed ID: 31091975
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of cyclin E1 overcomes temozolomide resistance in glioblastoma by Mcl-1 degradation.
Liang H; Chen Z; Sun L
Mol Carcinog; 2019 Aug; 58(8):1502-1511. PubMed ID: 31045274
[TBL] [Abstract][Full Text] [Related]
25. Targeting Aurora kinase B attenuates chemoresistance in glioblastoma via a synergistic manner with temozolomide.
Alafate W; Wang M; Zuo J; Wu W; Sun L; Liu C; Xie W; Wang J
Pathol Res Pract; 2019 Nov; 215(11):152617. PubMed ID: 31563286
[TBL] [Abstract][Full Text] [Related]
26. Honokiol Is a Potential Therapeutic Agent and Has a Synergistic Effect With 5-FU in Human Urothelial Cell Carcinoma Cells.
Lee MY; Shi CS; Hsu YC; Huang KJ; Chen SH; Zhao PW; Chung HC; Huang YC; Lee YR
Anticancer Res; 2019 Dec; 39(12):6555-6565. PubMed ID: 31810921
[TBL] [Abstract][Full Text] [Related]
27. Expression of survivin and p53 modulates honokiol-induced apoptosis in colorectal cancer cells.
Lai YJ; Lin CI; Wang CL; Chao JI
J Cell Biochem; 2014 Nov; 115(11):1888-99. PubMed ID: 24905183
[TBL] [Abstract][Full Text] [Related]
28. Impact of extremely low-frequency electromagnetic field (100 Hz, 100 G) exposure on human glioblastoma U87 cells during Temozolomide administration.
Ahmadi-Zeidabadi M; Akbarnejad Z; Esmaeeli M; Masoumi-Ardakani Y; Mohammadipoor-Ghasemabad L; Eskandary H
Electromagn Biol Med; 2019; 38(3):198-209. PubMed ID: 31179753
[TBL] [Abstract][Full Text] [Related]
29. Honokiol induces caspase-independent paraptosis via reactive oxygen species production that is accompanied by apoptosis in leukemia cells.
Wang Y; Zhu X; Yang Z; Zhao X
Biochem Biophys Res Commun; 2013 Jan; 430(3):876-82. PubMed ID: 23262230
[TBL] [Abstract][Full Text] [Related]
30. The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma.
Banelli B; Carra E; Barbieri F; Würth R; Parodi F; Pattarozzi A; Carosio R; Forlani A; Allemanni G; Marubbi D; Florio T; Daga A; Romani M
Cell Cycle; 2015; 14(21):3418-29. PubMed ID: 26566863
[TBL] [Abstract][Full Text] [Related]
31. Honokiol induces autophagy and apoptosis of osteosarcoma through PI3K/Akt/mTOR signaling pathway.
Li Z; Dong H; Li M; Wu Y; Liu Y; Zhao Y; Chen X; Ma M
Mol Med Rep; 2018 Feb; 17(2):2719-2723. PubMed ID: 29207060
[TBL] [Abstract][Full Text] [Related]
32. MAPK8 mediates resistance to temozolomide and apoptosis of glioblastoma cells through MAPK signaling pathway.
Xu P; Zhang G; Hou S; Sha LG
Biomed Pharmacother; 2018 Oct; 106():1419-1427. PubMed ID: 30119215
[TBL] [Abstract][Full Text] [Related]
33. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
[TBL] [Abstract][Full Text] [Related]
34. Down-modulation of Bcl-XL, release of cytochrome c and sequential activation of caspases during honokiol-induced apoptosis in human squamous lung cancer CH27 cells.
Yang SE; Hsieh MT; Tsai TH; Hsu SL
Biochem Pharmacol; 2002 May; 63(9):1641-51. PubMed ID: 12007567
[TBL] [Abstract][Full Text] [Related]
35. [Honokiol-induced apoptosis of human non-Hodgkin lymphoma Raji cells and its possible mechanism].
Chen W; Lin GW; Zhang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1918-21. PubMed ID: 22126780
[TBL] [Abstract][Full Text] [Related]
36. Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line.
Ashizawa T; Akiyama Y; Miyata H; Iizuka A; Komiyama M; Kume A; Omiya M; Sugino T; Asai A; Hayashi N; Mitsuya K; Nakasu Y; Yamaguchi K
Int J Oncol; 2014 Jul; 45(1):411-8. PubMed ID: 24820265
[TBL] [Abstract][Full Text] [Related]
37. Honokiol, a chemopreventive agent against skin cancer, induces cell cycle arrest and apoptosis in human epidermoid A431 cells.
Chilampalli C; Guillermo R; Kaushik RS; Young A; Chandrasekher G; Fahmy H; Dwivedi C
Exp Biol Med (Maywood); 2011 Nov; 236(11):1351-9. PubMed ID: 21908486
[TBL] [Abstract][Full Text] [Related]
38. Honokiol up-regulates prostacyclin synthease protein expression and inhibits endothelial cell apoptosis.
Zhang X; Chen S; Wang Y
Eur J Pharmacol; 2007 Jan; 554(1):1-7. PubMed ID: 17109844
[TBL] [Abstract][Full Text] [Related]
39. Study on Therapeutic Action and Mechanism of TMZ Combined with RITA Against Glioblastoma.
Wu Q; Cao Z; Xiao W; Zhu L; Xie Q; Li L; Zhang B; Zhao W
Cell Physiol Biochem; 2018; 51(6):2536-2546. PubMed ID: 30562758
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells.
Park EJ; Min HY; Chung HJ; Hong JY; Kang YJ; Hung TM; Youn UJ; Kim YS; Bae K; Kang SS; Lee SK
Cancer Lett; 2009 May; 277(2):133-40. PubMed ID: 19135778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]